APA (7th ed.) Citation

Privé, B. M., Janssen, M. J. R., van Oort, I. M., Muselaers, C. H. J., Jonker, M. A., van Gemert, W. A., . . . Oprea-Lager, D. E. (2021). Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: The BULLSEYE trial. Trials, 22(1), 1. https://doi.org/10.1186/s13063-021-05733-4

Chicago Style (17th ed.) Citation

Privé, Bastiaan M., et al. "Update to a Randomized Controlled Trial of Lutetium-177-PSMA in Oligo-metastatic Hormone-sensitive Prostate Cancer: The BULLSEYE Trial." Trials 22, no. 1 (2021): 1. https://doi.org/10.1186/s13063-021-05733-4.

MLA (9th ed.) Citation

Privé, Bastiaan M., et al. "Update to a Randomized Controlled Trial of Lutetium-177-PSMA in Oligo-metastatic Hormone-sensitive Prostate Cancer: The BULLSEYE Trial." Trials, vol. 22, no. 1, 2021, p. 1, https://doi.org/10.1186/s13063-021-05733-4.